TBPL2 Polyclonal Antibody

Rabbit Anti-TBPL2 Polyclonal Antibody

Product Specifications

Background

TBPL2 (TATA-Box Binding Protein Like 2) is a Protein Coding gene. Among its related pathways are RNA Polymerase II Transcription Initiation And Promoter Clearance and Epstein-Barr virus infection. GO annotations related to this gene include transcription factor activity, sequence-specific DNA binding. An important paralog of this gene is TBPL1.

CAS Number

9007-83-4

Product Name Alternative

TBPL2; TBP2; TRF3; TATA box-binding protein-like protein 2; TBP-like protein 2; TATA box-binding protein-related factor 3; TBP-related factor 3

Gene ID

387332

Accession Number

Q6SJ96

Reactivity

Human, Rat, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human TBPL2 at AA rangle: 50-130

Clonality

Polyclonal

Tag

TATA box-binding protein-like protein 2

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

41kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

TBPL2 Polyclonal Antibody detects endogenous levels of TBPL2 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200